Home/Pipeline/BGC10X

BGC10X

Broad Microvascular Unmet Needs

PreclinicalPlanned

Key Facts

Indication
Broad Microvascular Unmet Needs
Phase
Preclinical
Status
Planned
Company

About BioGenCell

Israeli cell‑therapy pioneer developing autologous blood‑derived treatments for microvascular and broader regenerative diseases.

View full company profile